Direct pharmacological AMPK activation inhibits mucosal SARS-CoV-2 infection by reducing lipid metabolism, restoring autophagy flux and the type I IFN response
Andréa Cottignies-CalamarteiD, Flora MarteauiD, Feifan He, Sandrine BelouzardiD, Jean DubuissoniD, Daniela TudoriD, Benoît ViolletiD, Morgane BomseliD
Abstract
AMP-activated protein kinase (AMPK) plays a central role in regulating cell energy balance. When activated, AMPK supresses energy-consuming pathways such as lipid and protein synthesis while increasing nutrient availability through the activation of autophagy. These pathways downstream AMPK activation contribute to SARS-CoV-2 infection, which hijacks autophagy and accumulates lipid droplets in viral factories to support viral replication. Here, we assessed the antiviral activity of the direct pan-AMPK allosteric activator MK-8722 in vitro. MK-8722 efficiently inhibited infection of Alpha and Omicron SARS-CoV-2 variants in Vero76 and human bronchial epithelial Calu-3 cells at micromolar concentration. This inhibition relied on restoring the autophagic flux, which redirected newly synthesized viral proteins for degradation, and on a reduction in lipid metabolism, which affected the viral factories. Furthermore, MK-8722 treatment increased the type I interferon (IFN-I) response. Post-infection treatment with MK-8722 was enough to inhibit efficiently viral replication and restore the IFN-I response. Finally, MK-8722 treatment did not alter the SARS-CoV-2-specific CD8+ T cell response mounted upon Spike vaccination. Overall, by activating AMPK, MK-8722 acts as an effective antiviral against SARS-CoV-2 infection, even when applied post-exposure, paving the way for preclinical tests aimed at inhibiting viral replication and improving patients symptoms. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=165 SRC="FIGDIR/small/582713v2_ufig1.gif" ALT="Figure 1"> View larger version (38K): org.highwire.dtl.DTLVardef@312825org.highwire.dtl.DTLVardef@142d0bborg.highwire.dtl.DTLVardef@195c989org.highwire.dtl.DTLVardef@e27ca7_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIMK-8722 exerts post-exposure antiviral activity C_LIO_LIMK-8722 induces a decrease in cellular lipid content C_LIO_LIMK-8722 promotes an increase in the autophagic flux of viral components C_LIO_LIMK-8722 promotes the restoration of the IFN-I activity C_LIO_LIMK-8722 antiviral activity is compatible with virus-specific T cell responses C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 7
- FWCI
- 3.71
- Field percentile
- top 8%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Analysis of SARS-CoV-2-controlled autophagy reveals spermidine, MK-2206, and niclosamide as putative antiviral therapeutics
N. C. Gassen, J. Papies, … M. A. Muller·bioRxiv·Apr 15, 2020
- Metformin Suppresses SARS-CoV-2 in Cell Culture
H. Parthasarathy, D. Tandel, … K. H. Harshan·bioRxiv·Nov 18, 2021
- SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial derived cells and cardiomyocytes
Y. Li, D. Renner, … S. R. Weiss·bioRxiv·Sep 24, 2020
- p38-MAPK is prerequisite for the synthesis of SARS-CoV-2 protein
P. Mittal, N. Khandelwal, … N. Kumar·bioRxiv·Sep 27, 2023
- Dietary αKG inhibits SARS CoV-2 infection and rescues inflamed lungs to restore normal O2 saturation in animals
S. Agarwal, S. Kaur, … P. Guchhait·bioRxiv·Apr 2, 2022
- Imperfect innate immune antagonism renders SARS-CoV-2 vulnerable towards IFN-γ and -{lambda}
M. Hayn, M. Hirschenberger, … K. M. J. Sparrer·bioRxiv·Oct 15, 2020